Reuters) - U.S. coronavirus infections surged by at least 129,606 on Friday, according to a Reuters tally, the third consecutive daily rise of more than 100,000 cases as a third wave of COVID-19 sweeps the United States.
From today, aspirin will be investigated in the world’s largest clinical trial of treatments for patients hospitalised with COVID-19. The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial is taking place in 176 hospital sites across the UK, and has so far recruited over 16,000 patients.
A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.
The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.
AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.
LONDON — Germany was lauded for its initial response to the coronavirus pandemic, but a four-week long return to strict public health measures has raised questions over the effectiveness of its strategy second time around.
Reuters) - As voters in the United States stream to the polls after a rancorous presidential campaign, Europe faces fresh curbs to contain a second wave of the coronavirus outbreak.
Recent Comments